Michel Delaage
Geen lopende functies
Profiel
Michel Delaage was the founder of Immunotech Laboratories, Inc. (founded in 2000) where he held the title of Scientific Director from 2000 to 2011, and Trophos SA (founded in 1998) where he held the title of Member-Supervisory Board.
Dr. Delaage's former jobs include Director-Supervisory Board at Sangamo Therapeutics France SAS and Member at Académie des Technologies.
Dr. Delaage received his undergraduate degree from Ecole Polytechnique.
Eerdere bekende functies van Michel Delaage
| Bedrijven | Functie | Einde |
|---|---|---|
Académie des Technologies
 Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
| IMMUNOTECH LABORATORIES, INC. | Oprichter | - |
| TXCELL | Directeur/Bestuurslid | 17-02-2011 |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Oprichter | - |
Opleiding van Michel Delaage
| Ecole Polytechnique | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IMMUNOTECH LABORATORIES, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Académie des Technologies
Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. |
